All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

CRISPR Therapeutics AG earnings schedule

CRISPR Therapeutics AG quarterly earnings, CRSP earnings report for 2024. When does CRISPR Therapeutics AG report earnings?
Add to widgets
Added to widgets

When does CRISPR Therapeutics AG report earnings?

CRISPR Therapeutics AG reports earnings every quartal, last CRISPR Therapeutics AG earnings report date was 31/03/2021.

How much is CRISPR Therapeutics AG earnings per share?

CRISPR Therapeutics AG estimated earnings per share was -1.51 $ last time.

When is CRISPR Therapeutics AG next earnings report?

Next CRISPR Therapeutics AG earnings call will be in June 2024.

CRISPR Therapeutics AG earnings per share of the company - one of the indicators of the company's income from the size of its value. Earnings per share is calculated simply - all the company's profit for the reporting financial period divided by the number of shares. It is clear that CRISPR Therapeutics AG earnings per share is a financial characteristic for a certain period. Profit of CRISPR Therapeutics AG - the organization’s reported profit for the financial interval specified by law.

Show:
to

CRISPR Therapeutics AG earnings report

CRISPR Therapeutics AG total profit is for reference only and is not interesting to individual shareholders. A much more interesting indicator is earnings per share, which directly affects the amount of dividends per share. The date of the profit report CRISPR Therapeutics AG is tied to the legislation of the country of registration of the company. All dates of CRISPR Therapeutics AG profit reports are shown in our schedule and our table.

CRISPR Therapeutics AG quarterly earnings

Earnings per share CRISPR Therapeutics AG is calculated by dividing the company's profit by the number of its shares. Earnings per share of CRISPR Therapeutics AG is considered for a certain financial period as well as financial reports on the company's total profit are issued. CRISPR Therapeutics AG earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). CRISPR Therapeutics AG quarterly earnings for financial analytics is the main interim report for the financial year.

CRSP earnings date Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
31/03/2021 -1.51 USD -
31/12/2020 -1.5 USD -
30/09/2020 -1.32 USD -155% ↓
30/06/2020 -1.3 USD +28.71% ↑
30/09/2019 2.4 USD -21.86% ↓
30/06/2019 -1.01 USD -29.944% ↓
31/03/2019 -0.93 USD -23.849% ↓
31/12/2018 -0.92 USD -14.432% ↓
30/09/2018 -1.07 USD -19.0926% ↓
30/06/2018 -0.82 USD -2.0619% ↓
31/03/2018 -0.62 USD -8.476% ↓
31/12/2017 -0.667 USD -26.584% ↓
30/09/2017 -0.62 USD -16.872% ↓
30/06/2017 -0.56 USD -
31/03/2017 -0.54 USD -
31/12/2016 1.42 USD -
30/09/2016 -2.77 USD -

CRISPR Therapeutics AG quarterly earnings per share is also one of the organization’s profitability indicators, although less popular than annual earnings per share. Last quarterly profit CRISPR Therapeutics AG is now considered to be quarterly profit for the last closed fiscal quarter of this year. Change in profit CRISPR Therapeutics AG for the year is a reference value showing the dynamics of profit compared to the same period last year. A change in CRISPR Therapeutics AG quarterly profit for the year is not so important as a change in CRISPR Therapeutics AG annual profit compared to last year.

The dynamics of the company's profit is displayed as a percentage. The profit history of CRISPR Therapeutics AG for the past years and reporting periods is in the table “Quarterly profit”. CRISPR Therapeutics AG quarterly earnings history is available online for each year and quarter over the past ten years. The CRISPR Therapeutics AG company’s profit database for previous years is collected from open sources.

CRISPR Therapeutics AG stocks data

CRISPR Therapeutics AG financials